

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 5.36612558 |
| 2 | vocalization behavior (GO:0071625) | 4.99198458 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.79427921 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 4.77516493 |
| 5 | urea metabolic process (GO:0019627) | 4.55388321 |
| 6 | urea cycle (GO:0000050) | 4.52774097 |
| 7 | regulation of guanylate cyclase activity (GO:0031282) | 4.51261929 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.39815380 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.36772595 |
| 10 | glutamate secretion (GO:0014047) | 4.24507511 |
| 11 | proline transport (GO:0015824) | 4.23288162 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.21832802 |
| 13 | nitrogen cycle metabolic process (GO:0071941) | 4.17594503 |
| 14 | locomotory exploration behavior (GO:0035641) | 4.16773794 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.16294415 |
| 16 | regulation of bile acid biosynthetic process (GO:0070857) | 4.12136799 |
| 17 | synaptic vesicle maturation (GO:0016188) | 4.12042973 |
| 18 | cellular glucuronidation (GO:0052695) | 4.11372528 |
| 19 | response to histamine (GO:0034776) | 4.08826143 |
| 20 | protein localization to synapse (GO:0035418) | 4.06170565 |
| 21 | peptide hormone processing (GO:0016486) | 4.03621805 |
| 22 | NADH metabolic process (GO:0006734) | 4.01632445 |
| 23 | glucuronate metabolic process (GO:0019585) | 3.99768720 |
| 24 | uronic acid metabolic process (GO:0006063) | 3.99768720 |
| 25 | drug metabolic process (GO:0017144) | 3.97744578 |
| 26 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.96877552 |
| 27 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.95955974 |
| 28 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.94940487 |
| 29 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.88233445 |
| 30 | exogenous drug catabolic process (GO:0042738) | 3.86725894 |
| 31 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.84631941 |
| 32 | drug catabolic process (GO:0042737) | 3.83528227 |
| 33 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.75538370 |
| 34 | glutamate receptor signaling pathway (GO:0007215) | 3.71251996 |
| 35 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.68734171 |
| 36 | angiotensin maturation (GO:0002003) | 3.67006461 |
| 37 | regulation of synaptic vesicle transport (GO:1902803) | 3.61044451 |
| 38 | flavonoid metabolic process (GO:0009812) | 3.60268731 |
| 39 | neuron cell-cell adhesion (GO:0007158) | 3.60055829 |
| 40 | exploration behavior (GO:0035640) | 3.59243027 |
| 41 | neurotransmitter secretion (GO:0007269) | 3.56118112 |
| 42 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.55709122 |
| 43 | negative regulation of cell killing (GO:0031342) | 3.47624034 |
| 44 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.47624034 |
| 45 | homocysteine metabolic process (GO:0050667) | 3.46070841 |
| 46 | layer formation in cerebral cortex (GO:0021819) | 3.44416723 |
| 47 | lipoprotein transport (GO:0042953) | 3.42810586 |
| 48 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.41703146 |
| 49 | bile acid and bile salt transport (GO:0015721) | 3.36177439 |
| 50 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.35953623 |
| 51 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.34501795 |
| 52 | neuronal action potential propagation (GO:0019227) | 3.33413494 |
| 53 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.29098666 |
| 54 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.28683433 |
| 55 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.23512526 |
| 56 | synaptic vesicle endocytosis (GO:0048488) | 3.21044466 |
| 57 | neuron-neuron synaptic transmission (GO:0007270) | 3.20687067 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 3.19498736 |
| 59 | cellular potassium ion homeostasis (GO:0030007) | 3.16645813 |
| 60 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.16160625 |
| 61 | L-phenylalanine metabolic process (GO:0006558) | 3.16160625 |
| 62 | regulation of postsynaptic membrane potential (GO:0060078) | 3.16049794 |
| 63 | arginine metabolic process (GO:0006525) | 3.15033424 |
| 64 | hormone catabolic process (GO:0042447) | 3.14687119 |
| 65 | fructose metabolic process (GO:0006000) | 3.14344427 |
| 66 | dendritic spine morphogenesis (GO:0060997) | 3.14100406 |
| 67 | regulation of synapse structural plasticity (GO:0051823) | 3.13697382 |
| 68 | synaptic transmission, glutamatergic (GO:0035249) | 3.11632160 |
| 69 | regulation of cGMP biosynthetic process (GO:0030826) | 3.11526774 |
| 70 | heme transport (GO:0015886) | 3.11413988 |
| 71 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.11293509 |
| 72 | L-phenylalanine catabolic process (GO:0006559) | 3.11293509 |
| 73 | neuron recognition (GO:0008038) | 3.09747423 |
| 74 | long-term memory (GO:0007616) | 3.08290197 |
| 75 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.07908352 |
| 76 | neurotransmitter transport (GO:0006836) | 3.07219914 |
| 77 | midgut development (GO:0007494) | 3.06874410 |
| 78 | regulation of vesicle fusion (GO:0031338) | 3.06347986 |
| 79 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.04792618 |
| 80 | long-term synaptic potentiation (GO:0060291) | 3.02656682 |
| 81 | phenylpropanoid metabolic process (GO:0009698) | 3.01780561 |
| 82 | negative regulation of hormone metabolic process (GO:0032351) | 3.01295540 |
| 83 | iron coordination entity transport (GO:1901678) | 3.00512604 |
| 84 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.99431354 |
| 85 | regulation of synaptic plasticity (GO:0048167) | 2.98599565 |
| 86 | citrulline biosynthetic process (GO:0019240) | 2.97058993 |
| 87 | positive regulation of membrane potential (GO:0045838) | 2.96192514 |
| 88 | omega-hydroxylase P450 pathway (GO:0097267) | 2.95261006 |
| 89 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.94553828 |
| 90 | activation of protein kinase A activity (GO:0034199) | 2.94002640 |
| 91 | regulation of glutamate secretion (GO:0014048) | 2.93907389 |
| 92 | gamma-aminobutyric acid transport (GO:0015812) | 2.93133254 |
| 93 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.92130675 |
| 94 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.92056330 |
| 95 | intestinal absorption (GO:0050892) | 2.91986991 |
| 96 | bile acid metabolic process (GO:0008206) | 2.91133671 |
| 97 | regulation of triglyceride catabolic process (GO:0010896) | 2.90718651 |
| 98 | serotonin metabolic process (GO:0042428) | 2.90243910 |
| 99 | potassium ion homeostasis (GO:0055075) | 2.90205765 |
| 100 | fear response (GO:0042596) | 2.87280663 |
| 101 | positive regulation of vesicle fusion (GO:0031340) | 2.87108204 |
| 102 | phosphate ion transmembrane transport (GO:0035435) | 2.86168095 |
| 103 | digestion (GO:0007586) | 2.83191310 |
| 104 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.82544556 |
| 105 | sodium ion homeostasis (GO:0055078) | 2.82491244 |
| 106 | regulation of neurotransmitter secretion (GO:0046928) | 2.82376673 |
| 107 | vitamin transport (GO:0051180) | 2.82280911 |
| 108 | primary amino compound metabolic process (GO:1901160) | 2.80681527 |
| 109 | regulation of dendritic spine development (GO:0060998) | 2.80315712 |
| 110 | positive regulation of neurotransmitter transport (GO:0051590) | 2.77712688 |
| 111 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.77303323 |
| 112 | regulation of neurotransmitter levels (GO:0001505) | 2.76790951 |
| 113 | auditory receptor cell differentiation (GO:0042491) | 2.75870255 |
| 114 | vesicle transport along microtubule (GO:0047496) | 2.75869471 |
| 115 | drug transmembrane transport (GO:0006855) | 2.74917934 |
| 116 | ketone body metabolic process (GO:1902224) | 2.74218657 |
| 117 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.72843725 |
| 118 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.71920607 |
| 119 | endocrine process (GO:0050886) | 2.71920607 |
| 120 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.71920607 |
| 121 | behavioral defense response (GO:0002209) | 2.71754741 |
| 122 | behavioral fear response (GO:0001662) | 2.71754741 |
| 123 | sodium ion export (GO:0071436) | 2.70385208 |
| 124 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.67799861 |
| 125 | presynaptic membrane assembly (GO:0097105) | 2.67497148 |
| 126 | ethanol oxidation (GO:0006069) | 2.65870817 |
| 127 | L-amino acid import (GO:0043092) | 2.65420383 |
| 128 | neutral amino acid transport (GO:0015804) | 2.65299667 |
| 129 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.65220344 |
| 130 | axonal fasciculation (GO:0007413) | 2.64699967 |
| 131 | alkaloid metabolic process (GO:0009820) | 2.64348993 |
| 132 | potassium ion import (GO:0010107) | 2.62885568 |
| 133 | detection of calcium ion (GO:0005513) | 2.62852104 |
| 134 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.62678609 |
| 135 | intestinal cholesterol absorption (GO:0030299) | 2.62506156 |
| 136 | phagosome maturation (GO:0090382) | 2.62445485 |
| 137 | vitamin biosynthetic process (GO:0009110) | 2.60498892 |
| 138 | glycine transport (GO:0015816) | 2.60237226 |
| 139 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.59889769 |
| 140 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.59811950 |
| 141 | behavioral response to cocaine (GO:0048148) | 2.59516197 |
| 142 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.59222062 |
| 143 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.59222062 |
| 144 | C4-dicarboxylate transport (GO:0015740) | 2.58993719 |
| 145 | urate metabolic process (GO:0046415) | 2.58077048 |
| 146 | regulation of neurotransmitter transport (GO:0051588) | 2.57653707 |
| 147 | diacylglycerol metabolic process (GO:0046339) | 2.57619628 |
| 148 | negative regulation of amino acid transport (GO:0051956) | 2.57588324 |
| 149 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.57522663 |
| 150 | long term synaptic depression (GO:0060292) | 2.57357466 |
| 151 | citrulline metabolic process (GO:0000052) | 2.57243748 |
| 152 | mating behavior (GO:0007617) | 2.56306830 |
| 153 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.56128370 |
| 154 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.56128370 |
| 155 | cellular sodium ion homeostasis (GO:0006883) | 2.55431496 |
| 156 | positive regulation of synapse maturation (GO:0090129) | 2.53840837 |
| 157 | regulation of systemic arterial blood pressure (GO:0003073) | 2.53800075 |
| 158 | myelin maintenance (GO:0043217) | 2.53506420 |
| 159 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.53330080 |
| 160 | protein targeting to Golgi (GO:0000042) | 2.53026765 |
| 161 | cellular response to ammonium ion (GO:0071242) | 2.52822029 |
| 162 | drinking behavior (GO:0042756) | 2.52480261 |
| 163 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.51598678 |
| 164 | oxaloacetate metabolic process (GO:0006107) | 2.51407485 |
| 165 | positive regulation of glycolytic process (GO:0045821) | 2.50835539 |
| 166 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.50509523 |
| 167 | membrane depolarization (GO:0051899) | 2.49141836 |
| 168 | regulation of cGMP metabolic process (GO:0030823) | 2.49053338 |
| 169 | regulation of exocytosis (GO:0017157) | 2.47587629 |
| 170 | synaptic transmission (GO:0007268) | 2.47477270 |
| 171 | regulation of protein kinase A signaling (GO:0010738) | 2.47430479 |
| 172 | positive regulation of synaptic transmission (GO:0050806) | 2.47118759 |
| 173 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.46758741 |
| 174 | clathrin coat assembly (GO:0048268) | 2.46539392 |
| 175 | regulation of synaptic transmission (GO:0050804) | 2.45977663 |
| 176 | positive regulation of dendritic spine development (GO:0060999) | 2.45563173 |
| 177 | establishment of synaptic vesicle localization (GO:0097480) | 2.44935304 |
| 178 | synaptic vesicle transport (GO:0048489) | 2.44935304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.97329558 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.17418250 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.11800701 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.84859201 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.75661701 |
| 6 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.67545935 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.52893885 |
| 8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.51196038 |
| 9 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.38454518 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.30829625 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.30201715 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.30201715 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.27930703 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.27280154 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.24345366 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.22288897 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.21299722 |
| 18 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.15745635 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.14854128 |
| 20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.13993951 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.13935841 |
| 22 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.05863199 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.97049967 |
| 24 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.92941147 |
| 25 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.86963666 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.86160548 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.81730143 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.79763433 |
| 29 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.78586062 |
| 30 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.77027504 |
| 31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.76998128 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74083800 |
| 33 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.73552870 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.70135968 |
| 35 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.69132926 |
| 36 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68964493 |
| 37 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.65900177 |
| 38 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.65299637 |
| 39 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.63657516 |
| 40 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.57119589 |
| 41 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.55758433 |
| 42 | TP53_16413492_ChIP-PET_HCT116_Human | 1.53960830 |
| 43 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.53925644 |
| 44 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.53585051 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.49483225 |
| 46 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.49349492 |
| 47 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48551521 |
| 48 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.47784646 |
| 49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.47779021 |
| 50 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.45747684 |
| 51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.44787146 |
| 52 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.36035185 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34298207 |
| 54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.34253653 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33527377 |
| 56 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.33003842 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32831463 |
| 58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32778346 |
| 59 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.32291125 |
| 60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26768284 |
| 61 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.25774988 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25335952 |
| 63 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.24765487 |
| 64 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24438325 |
| 65 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.23980221 |
| 66 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23734825 |
| 67 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.23406586 |
| 68 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.23069276 |
| 69 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22861096 |
| 70 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.22745473 |
| 71 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21834417 |
| 72 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20960498 |
| 73 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20558166 |
| 74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.20555404 |
| 75 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.19290916 |
| 76 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.19115960 |
| 77 | VDR_22108803_ChIP-Seq_LS180_Human | 1.19065694 |
| 78 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.16276332 |
| 79 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15498770 |
| 80 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.15477569 |
| 81 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15302092 |
| 82 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14494608 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13964415 |
| 84 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.13247839 |
| 85 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12838750 |
| 86 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12156213 |
| 87 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.10555343 |
| 88 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10477285 |
| 89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09688575 |
| 90 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.09391826 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08254260 |
| 92 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08242438 |
| 93 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07417214 |
| 94 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07317211 |
| 95 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07052184 |
| 96 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06817635 |
| 97 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.05852773 |
| 98 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.05445080 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05339655 |
| 100 | CBP_21632823_ChIP-Seq_H3396_Human | 1.05272578 |
| 101 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03444384 |
| 102 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.03443297 |
| 103 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02276025 |
| 104 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02019281 |
| 105 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.00642068 |
| 106 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.99366124 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99299213 |
| 108 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99211009 |
| 109 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.98862338 |
| 110 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.97813285 |
| 111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97805843 |
| 112 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97804840 |
| 113 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97415137 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97033657 |
| 115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96985304 |
| 116 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.96598845 |
| 117 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.96304620 |
| 118 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.96304620 |
| 119 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94831948 |
| 120 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.94720910 |
| 121 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94239528 |
| 122 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.93637845 |
| 123 | TBL1_22424771_ChIP-Seq_293T_Human | 0.93528167 |
| 124 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.93522984 |
| 125 | AR_19668381_ChIP-Seq_PC3_Human | 0.93505319 |
| 126 | NCOR_22424771_ChIP-Seq_293T_Human | 0.93218226 |
| 127 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92730352 |
| 128 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92374975 |
| 129 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92128206 |
| 130 | NFYB_21822215_ChIP-Seq_K562_Human | 0.91496444 |
| 131 | JUN_21703547_ChIP-Seq_K562_Human | 0.91159351 |
| 132 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91153472 |
| 133 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91090646 |
| 134 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91090646 |
| 135 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90927357 |
| 136 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90926383 |
| 137 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.90726765 |
| 138 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.90143730 |
| 139 | KDM2B_26808549_Chip-Seq_REH_Human | 0.89714333 |
| 140 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89315538 |
| 141 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.88971698 |
| 142 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88200519 |
| 143 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86814541 |
| 144 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.83958008 |
| 145 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83359469 |
| 146 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.82688690 |
| 147 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.81089107 |
| 148 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81011008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.80692826 |
| 2 | MP0003880_abnormal_central_pattern | 4.57125612 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.17927584 |
| 4 | MP0002822_catalepsy | 4.13549528 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.73712550 |
| 6 | MP0004270_analgesia | 3.66064632 |
| 7 | MP0009745_abnormal_behavioral_response | 3.32979636 |
| 8 | MP0005365_abnormal_bile_salt | 3.13562755 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.06411922 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 2.97858234 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.94619869 |
| 12 | MP0002064_seizures | 2.87619546 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.64941185 |
| 14 | MP0005360_urolithiasis | 2.63334653 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.60176042 |
| 16 | MP0001440_abnormal_grooming_behavior | 2.54202703 |
| 17 | MP0003329_amyloid_beta_deposits | 2.53950488 |
| 18 | MP0002736_abnormal_nociception_after | 2.47450397 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.37876780 |
| 20 | MP0009046_muscle_twitch | 2.30104265 |
| 21 | MP0005332_abnormal_amino_acid | 2.29900992 |
| 22 | MP0002735_abnormal_chemical_nociception | 2.12293133 |
| 23 | MP0003195_calcinosis | 2.06119126 |
| 24 | MP0002733_abnormal_thermal_nociception | 2.05631083 |
| 25 | MP0002272_abnormal_nervous_system | 2.04093782 |
| 26 | MP0001970_abnormal_pain_threshold | 1.98635146 |
| 27 | MP0001486_abnormal_startle_reflex | 1.98298094 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.94126677 |
| 29 | MP0000604_amyloidosis | 1.90948700 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.90352698 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.89938833 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.77726218 |
| 33 | MP0004924_abnormal_behavior | 1.74382426 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.74382426 |
| 35 | MP0003252_abnormal_bile_duct | 1.71842314 |
| 36 | MP0003868_abnormal_feces_composition | 1.66057676 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.62195161 |
| 38 | MP0004858_abnormal_nervous_system | 1.60446940 |
| 39 | MP0003879_abnormal_hair_cell | 1.58757095 |
| 40 | MP0002067_abnormal_sensory_capabilities | 1.55553780 |
| 41 | MP0001529_abnormal_vocalization | 1.52935285 |
| 42 | MP0010386_abnormal_urinary_bladder | 1.51350538 |
| 43 | MP0003075_altered_response_to | 1.49852574 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.45050377 |
| 45 | MP0004043_abnormal_pH_regulation | 1.42768596 |
| 46 | MP0005636_abnormal_mineral_homeostasis | 1.42729799 |
| 47 | MP0003303_peritoneal_inflammation | 1.42703242 |
| 48 | MP0008874_decreased_physiological_sensi | 1.40416658 |
| 49 | MP0005423_abnormal_somatic_nervous | 1.40109885 |
| 50 | MP0008872_abnormal_physiological_respon | 1.40063262 |
| 51 | MP0006276_abnormal_autonomic_nervous | 1.39433575 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.38514769 |
| 53 | MP0003633_abnormal_nervous_system | 1.37580765 |
| 54 | MP0001905_abnormal_dopamine_level | 1.34520112 |
| 55 | MP0004510_myositis | 1.33993041 |
| 56 | MP0005535_abnormal_body_temperature | 1.32933022 |
| 57 | MP0004264_abnormal_extraembryonic_tissu | 1.32234109 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.31269928 |
| 59 | MP0002118_abnormal_lipid_homeostasis | 1.29465986 |
| 60 | MP0002557_abnormal_social/conspecific_i | 1.27873363 |
| 61 | MP0001764_abnormal_homeostasis | 1.26367383 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.26150159 |
| 63 | MP0004811_abnormal_neuron_physiology | 1.25405281 |
| 64 | MP0008569_lethality_at_weaning | 1.23863265 |
| 65 | MP0003787_abnormal_imprinting | 1.22130681 |
| 66 | MP0010329_abnormal_lipoprotein_level | 1.16216281 |
| 67 | MP0001756_abnormal_urination | 1.13440258 |
| 68 | MP0005166_decreased_susceptibility_to | 1.08509276 |
| 69 | MP0003631_nervous_system_phenotype | 1.08208906 |
| 70 | MP0000778_abnormal_nervous_system | 1.07939806 |
| 71 | MP0008875_abnormal_xenobiotic_pharmacok | 1.07861328 |
| 72 | MP0002066_abnormal_motor_capabilities/c | 1.05755527 |
| 73 | MP0002184_abnormal_innervation | 1.04572051 |
| 74 | MP0002638_abnormal_pupillary_reflex | 1.04006766 |
| 75 | MP0002078_abnormal_glucose_homeostasis | 1.03002650 |
| 76 | MP0001664_abnormal_digestion | 1.01892330 |
| 77 | MP0001485_abnormal_pinna_reflex | 0.96354438 |
| 78 | MP0000003_abnormal_adipose_tissue | 0.95729903 |
| 79 | MP0004484_altered_response_of | 0.95237718 |
| 80 | MP0005551_abnormal_eye_electrophysiolog | 0.94706820 |
| 81 | MP0010678_abnormal_skin_adnexa | 0.94060074 |
| 82 | MP0002693_abnormal_pancreas_physiology | 0.92713385 |
| 83 | MP0003953_abnormal_hormone_level | 0.91660789 |
| 84 | MP0001944_abnormal_pancreas_morphology | 0.91471598 |
| 85 | MP0000955_abnormal_spinal_cord | 0.90454008 |
| 86 | MP0005448_abnormal_energy_balance | 0.89062420 |
| 87 | MP0002971_abnormal_brown_adipose | 0.87910207 |
| 88 | MP0005310_abnormal_salivary_gland | 0.87463001 |
| 89 | MP0005379_endocrine/exocrine_gland_phen | 0.87428135 |
| 90 | MP0001188_hyperpigmentation | 0.86974289 |
| 91 | MP0003690_abnormal_glial_cell | 0.86715402 |
| 92 | MP0002254_reproductive_system_inflammat | 0.85607979 |
| 93 | MP0000538_abnormal_urinary_bladder | 0.84996255 |
| 94 | MP0005409_darkened_coat_color | 0.84317818 |
| 95 | MP0001984_abnormal_olfaction | 0.84248549 |
| 96 | MP0005085_abnormal_gallbladder_physiolo | 0.84219968 |
| 97 | MP0002069_abnormal_eating/drinking_beha | 0.84135364 |
| 98 | MP0003718_maternal_effect | 0.83478247 |
| 99 | MP0009840_abnormal_foam_cell | 0.81467355 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.81381279 |
| 101 | MP0001663_abnormal_digestive_system | 0.80593679 |
| 102 | MP0002882_abnormal_neuron_morphology | 0.80372794 |
| 103 | MP0010352_gastrointestinal_tract_polyps | 0.80015759 |
| 104 | MP0003283_abnormal_digestive_organ | 0.79561386 |
| 105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78698521 |
| 106 | MP0004147_increased_porphyrin_level | 0.76182170 |
| 107 | MP0005646_abnormal_pituitary_gland | 0.75819966 |
| 108 | MP0000569_abnormal_digit_pigmentation | 0.75191479 |
| 109 | MP0001502_abnormal_circadian_rhythm | 0.74889305 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.74136897 |
| 111 | MP0000230_abnormal_systemic_arterial | 0.71880822 |
| 112 | MP0000609_abnormal_liver_physiology | 0.70577106 |
| 113 | MP0000462_abnormal_digestive_system | 0.69463839 |
| 114 | MP0005645_abnormal_hypothalamus_physiol | 0.69404097 |
| 115 | MP0004883_abnormal_blood_vessel | 0.69044464 |
| 116 | MP0000013_abnormal_adipose_tissue | 0.68415037 |
| 117 | MP0002090_abnormal_vision | 0.68140250 |
| 118 | MP0005174_abnormal_tail_pigmentation | 0.66920776 |
| 119 | MP0001177_atelectasis | 0.66130730 |
| 120 | MP0004142_abnormal_muscle_tone | 0.63503642 |
| 121 | MP0002229_neurodegeneration | 0.63044353 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.62460649 |
| 123 | MP0003436_decreased_susceptibility_to | 0.61831707 |
| 124 | MP0005464_abnormal_platelet_physiology | 0.61750404 |
| 125 | MP0003632_abnormal_nervous_system | 0.59943231 |
| 126 | MP0003656_abnormal_erythrocyte_physiolo | 0.59513817 |
| 127 | MP0004130_abnormal_muscle_cell | 0.58657801 |
| 128 | MP0003172_abnormal_lysosome_physiology | 0.58594760 |
| 129 | MP0002152_abnormal_brain_morphology | 0.58462746 |
| 130 | MP0004085_abnormal_heartbeat | 0.58371825 |
| 131 | MP0003191_abnormal_cellular_cholesterol | 0.58042096 |
| 132 | MP0001765_abnormal_ion_homeostasis | 0.57650875 |
| 133 | MP0003866_abnormal_defecation | 0.56620381 |
| 134 | MP0009379_abnormal_foot_pigmentation | 0.55607652 |
| 135 | MP0004885_abnormal_endolymph | 0.54854226 |
| 136 | MP0005381_digestive/alimentary_phenotyp | 0.54463895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.59863571 |
| 2 | Myokymia (HP:0002411) | 5.53886685 |
| 3 | Focal seizures (HP:0007359) | 5.51398336 |
| 4 | Visual hallucinations (HP:0002367) | 5.46055216 |
| 5 | Hydroxyprolinuria (HP:0003080) | 4.98060229 |
| 6 | Abnormality of proline metabolism (HP:0010907) | 4.98060229 |
| 7 | Atonic seizures (HP:0010819) | 4.53082631 |
| 8 | Epileptic encephalopathy (HP:0200134) | 4.31951409 |
| 9 | Absence seizures (HP:0002121) | 4.27966232 |
| 10 | Cerebral inclusion bodies (HP:0100314) | 4.17940822 |
| 11 | Febrile seizures (HP:0002373) | 4.08156099 |
| 12 | Abnormality of vitamin B metabolism (HP:0004340) | 4.05503179 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 4.04535349 |
| 14 | Hyperventilation (HP:0002883) | 3.94619172 |
| 15 | Malnutrition (HP:0004395) | 3.91616476 |
| 16 | Dialeptic seizures (HP:0011146) | 3.88289925 |
| 17 | Papilledema (HP:0001085) | 3.85278458 |
| 18 | Abnormality of vitamin metabolism (HP:0100508) | 3.70744976 |
| 19 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.62564387 |
| 20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.55884917 |
| 21 | Supranuclear gaze palsy (HP:0000605) | 3.48676808 |
| 22 | Neurofibrillary tangles (HP:0002185) | 3.47742710 |
| 23 | Confusion (HP:0001289) | 3.47355814 |
| 24 | Amblyopia (HP:0000646) | 3.47102799 |
| 25 | Alkalosis (HP:0001948) | 3.43257688 |
| 26 | Fat malabsorption (HP:0002630) | 3.42465955 |
| 27 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.35669190 |
| 28 | Poor eye contact (HP:0000817) | 3.33491960 |
| 29 | Abnormality of urine glucose concentration (HP:0011016) | 3.31185457 |
| 30 | Glycosuria (HP:0003076) | 3.31185457 |
| 31 | Abnormal social behavior (HP:0012433) | 3.27677182 |
| 32 | Impaired social interactions (HP:0000735) | 3.27677182 |
| 33 | Broad-based gait (HP:0002136) | 3.21677639 |
| 34 | Hypoglycemic coma (HP:0001325) | 3.16297867 |
| 35 | Increased circulating renin level (HP:0000848) | 3.02557559 |
| 36 | Ketoacidosis (HP:0001993) | 3.01609712 |
| 37 | Mutism (HP:0002300) | 2.95870583 |
| 38 | Metabolic alkalosis (HP:0200114) | 2.95100606 |
| 39 | Progressive cerebellar ataxia (HP:0002073) | 2.93316632 |
| 40 | Abnormal eating behavior (HP:0100738) | 2.90241134 |
| 41 | Hyperammonemia (HP:0001987) | 2.88106914 |
| 42 | Proximal tubulopathy (HP:0000114) | 2.83008304 |
| 43 | Hyperglycinuria (HP:0003108) | 2.80946397 |
| 44 | Acanthocytosis (HP:0001927) | 2.80260838 |
| 45 | Abnormality of renin-angiotensin system (HP:0000847) | 2.77427576 |
| 46 | Anxiety (HP:0000739) | 2.74615156 |
| 47 | Congenital sensorineural hearing impairment (HP:0008527) | 2.72550586 |
| 48 | Progressive inability to walk (HP:0002505) | 2.70019633 |
| 49 | Hypoglycemic seizures (HP:0002173) | 2.67793450 |
| 50 | Abnormality of magnesium homeostasis (HP:0004921) | 2.66615078 |
| 51 | Inability to walk (HP:0002540) | 2.66612608 |
| 52 | Hyperglycemia (HP:0003074) | 2.66144804 |
| 53 | Dysmetria (HP:0001310) | 2.64961706 |
| 54 | Chronic diarrhea (HP:0002028) | 2.62792497 |
| 55 | Hypolipoproteinemia (HP:0010981) | 2.62502639 |
| 56 | Truncal ataxia (HP:0002078) | 2.62041920 |
| 57 | Drooling (HP:0002307) | 2.61293364 |
| 58 | Excessive salivation (HP:0003781) | 2.61293364 |
| 59 | Abnormality of binocular vision (HP:0011514) | 2.60767358 |
| 60 | Diplopia (HP:0000651) | 2.60767358 |
| 61 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.60069880 |
| 62 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.59457281 |
| 63 | Xanthomatosis (HP:0000991) | 2.57134500 |
| 64 | Action tremor (HP:0002345) | 2.56141951 |
| 65 | Depression (HP:0000716) | 2.55725066 |
| 66 | Steatorrhea (HP:0002570) | 2.54985171 |
| 67 | Polyphagia (HP:0002591) | 2.51790574 |
| 68 | Widely patent fontanelles and sutures (HP:0004492) | 2.51734222 |
| 69 | Pigmentary retinal degeneration (HP:0001146) | 2.51604376 |
| 70 | Abnormality of glycine metabolism (HP:0010895) | 2.49850530 |
| 71 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.49850530 |
| 72 | Insidious onset (HP:0003587) | 2.49587959 |
| 73 | Termporal pattern (HP:0011008) | 2.49587959 |
| 74 | Inappropriate behavior (HP:0000719) | 2.48595231 |
| 75 | Gaze-evoked nystagmus (HP:0000640) | 2.48127270 |
| 76 | Stereotypic behavior (HP:0000733) | 2.45946176 |
| 77 | Decreased circulating renin level (HP:0003351) | 2.44166945 |
| 78 | Systemic lupus erythematosus (HP:0002725) | 2.43131956 |
| 79 | Dysdiadochokinesis (HP:0002075) | 2.42977153 |
| 80 | Gout (HP:0001997) | 2.42833982 |
| 81 | Generalized myoclonic seizures (HP:0002123) | 2.40302250 |
| 82 | Postural instability (HP:0002172) | 2.39554462 |
| 83 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39413059 |
| 84 | Irritability (HP:0000737) | 2.39055088 |
| 85 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.37937401 |
| 86 | Psychosis (HP:0000709) | 2.36939604 |
| 87 | Absent speech (HP:0001344) | 2.34203003 |
| 88 | Hyperuricemia (HP:0002149) | 2.33678581 |
| 89 | Increased purine levels (HP:0004368) | 2.33678581 |
| 90 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.32459347 |
| 91 | Ketosis (HP:0001946) | 2.30738925 |
| 92 | Conjugated hyperbilirubinemia (HP:0002908) | 2.29963440 |
| 93 | Exotropia (HP:0000577) | 2.29272323 |
| 94 | Hypomagnesemia (HP:0002917) | 2.29267056 |
| 95 | Eczematoid dermatitis (HP:0000976) | 2.29094970 |
| 96 | Delusions (HP:0000746) | 2.28610675 |
| 97 | Global brain atrophy (HP:0002283) | 2.27758665 |
| 98 | Symptomatic seizures (HP:0011145) | 2.25373532 |
| 99 | Ileus (HP:0002595) | 2.24423899 |
| 100 | Megaloblastic anemia (HP:0001889) | 2.23158851 |
| 101 | Late onset (HP:0003584) | 2.21334866 |
| 102 | Generalized hypopigmentation of hair (HP:0011358) | 2.20332210 |
| 103 | Abnormal gallbladder physiology (HP:0012438) | 2.19728768 |
| 104 | Cholecystitis (HP:0001082) | 2.19728768 |
| 105 | Epileptiform EEG discharges (HP:0011182) | 2.19727279 |
| 106 | Amyloidosis (HP:0011034) | 2.16784413 |
| 107 | Hyperphosphaturia (HP:0003109) | 2.15919930 |
| 108 | Rapidly progressive (HP:0003678) | 2.14937752 |
| 109 | Metabolic acidosis (HP:0001942) | 2.14392018 |
| 110 | Hyperactive renin-angiotensin system (HP:0000841) | 2.12880965 |
| 111 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.12204164 |
| 112 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.11510829 |
| 113 | Fair hair (HP:0002286) | 2.11038735 |
| 114 | Apathy (HP:0000741) | 2.10751452 |
| 115 | Nephrolithiasis (HP:0000787) | 2.09385992 |
| 116 | Abdominal distention (HP:0003270) | 2.09374407 |
| 117 | Impaired smooth pursuit (HP:0007772) | 2.09178518 |
| 118 | Abnormality of purine metabolism (HP:0004352) | 2.08505895 |
| 119 | Akinesia (HP:0002304) | 2.07310790 |
| 120 | Bradykinesia (HP:0002067) | 2.06708036 |
| 121 | Dysmetric saccades (HP:0000641) | 2.06588221 |
| 122 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.05947509 |
| 123 | Abnormal urine phosphate concentration (HP:0012599) | 2.05554085 |
| 124 | EEG with generalized epileptiform discharges (HP:0011198) | 2.02744349 |
| 125 | Status epilepticus (HP:0002133) | 2.02288341 |
| 126 | Limb dystonia (HP:0002451) | 2.01156215 |
| 127 | Abnormality of nucleobase metabolism (HP:0010932) | 2.00501999 |
| 128 | Epidermoid cyst (HP:0200040) | 1.99518891 |
| 129 | Autoimmune thrombocytopenia (HP:0001973) | 1.99312719 |
| 130 | Recurrent abscess formation (HP:0002722) | 1.98405713 |
| 131 | Vascular calcification (HP:0004934) | 1.97870516 |
| 132 | Recurrent bacterial skin infections (HP:0005406) | 1.97856702 |
| 133 | Neuronal loss in central nervous system (HP:0002529) | 1.97791590 |
| 134 | Abnormality of the corticospinal tract (HP:0002492) | 1.97576097 |
| 135 | Syncope (HP:0001279) | 1.96865624 |
| 136 | Lethargy (HP:0001254) | 1.96766078 |
| 137 | Torticollis (HP:0000473) | 1.96081369 |
| 138 | J-shaped sella turcica (HP:0002680) | 1.94896029 |
| 139 | Hypothermia (HP:0002045) | 1.94576618 |
| 140 | Diminished motivation (HP:0000745) | 1.92961507 |
| 141 | Cerebral hemorrhage (HP:0001342) | 1.92147112 |
| 142 | Poikilocytosis (HP:0004447) | 1.91207608 |
| 143 | Hyperphosphatemia (HP:0002905) | 1.91183067 |
| 144 | Clonus (HP:0002169) | 1.91093584 |
| 145 | Hypotension (HP:0002615) | 1.90752673 |
| 146 | Ankle clonus (HP:0011448) | 1.89121698 |
| 147 | Orthostatic hypotension (HP:0001278) | 1.88786626 |
| 148 | Urinary urgency (HP:0000012) | 1.87635032 |
| 149 | Focal dystonia (HP:0004373) | 1.86642225 |
| 150 | Gingivitis (HP:0000230) | 1.85887985 |
| 151 | Intention tremor (HP:0002080) | 1.85572993 |
| 152 | Abnormality of salivation (HP:0100755) | 1.85060100 |
| 153 | Facial shape deformation (HP:0011334) | 1.84824159 |
| 154 | Potter facies (HP:0002009) | 1.84824159 |
| 155 | Increased IgE level (HP:0003212) | 1.84147532 |
| 156 | Ventricular fibrillation (HP:0001663) | 1.83737588 |
| 157 | Focal segmental glomerulosclerosis (HP:0000097) | 1.83737349 |
| 158 | Hemiparesis (HP:0001269) | 1.83322798 |
| 159 | Lower limb amyotrophy (HP:0007210) | 1.83307773 |
| 160 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.83038953 |
| 161 | Hypsarrhythmia (HP:0002521) | 1.82763574 |
| 162 | Hyperthyroidism (HP:0000836) | 1.81317374 |
| 163 | Blue irides (HP:0000635) | 1.79210940 |
| 164 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.78595433 |
| 165 | Clumsiness (HP:0002312) | 1.78589170 |
| 166 | Posterior subcapsular cataract (HP:0007787) | 1.77514376 |
| 167 | Ankyloglossia (HP:0010296) | 1.77194635 |
| 168 | Postural tremor (HP:0002174) | 1.76642063 |
| 169 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.76333450 |
| 170 | Hypobetalipoproteinemia (HP:0003563) | 1.75060804 |
| 171 | Cerebral edema (HP:0002181) | 1.74129853 |
| 172 | Scanning speech (HP:0002168) | 1.70374065 |
| 173 | Resting tremor (HP:0002322) | 1.69570477 |
| 174 | Protruding tongue (HP:0010808) | 1.69477782 |
| 175 | Lower limb asymmetry (HP:0100559) | 1.69294000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 4.43711305 |
| 2 | RIPK4 | 4.29040715 |
| 3 | EPHA4 | 4.11926912 |
| 4 | MAP3K9 | 3.89575325 |
| 5 | NTRK3 | 3.76112242 |
| 6 | MAP3K12 | 3.38368108 |
| 7 | PDK2 | 3.08982070 |
| 8 | STK39 | 2.89629898 |
| 9 | MAP3K4 | 2.79520896 |
| 10 | KSR2 | 2.68015699 |
| 11 | OXSR1 | 2.61863944 |
| 12 | DAPK2 | 2.61381625 |
| 13 | MAP2K7 | 2.38813833 |
| 14 | WNK4 | 2.30493829 |
| 15 | MAP2K4 | 2.24275328 |
| 16 | MINK1 | 2.19943771 |
| 17 | NTRK1 | 2.08500667 |
| 18 | GRK6 | 2.07219820 |
| 19 | GRK5 | 2.06288126 |
| 20 | MAP3K13 | 2.05083065 |
| 21 | ARAF | 2.03480282 |
| 22 | DAPK1 | 1.88063646 |
| 23 | FRK | 1.83624931 |
| 24 | PLK2 | 1.79254432 |
| 25 | MARK1 | 1.78421144 |
| 26 | FES | 1.76359405 |
| 27 | FGR | 1.74139848 |
| 28 | MAP3K2 | 1.73442563 |
| 29 | PNCK | 1.65279307 |
| 30 | MET | 1.62245968 |
| 31 | PINK1 | 1.62136557 |
| 32 | EPHA2 | 1.61038839 |
| 33 | PHKG2 | 1.55138911 |
| 34 | PHKG1 | 1.55138911 |
| 35 | NME1 | 1.51907066 |
| 36 | SIK2 | 1.50264014 |
| 37 | PTK2B | 1.45803928 |
| 38 | KSR1 | 1.45725151 |
| 39 | CAMKK1 | 1.40736920 |
| 40 | UHMK1 | 1.36509697 |
| 41 | NEK6 | 1.36262698 |
| 42 | BMPR2 | 1.34614046 |
| 43 | CASK | 1.34289454 |
| 44 | PAK6 | 1.33592431 |
| 45 | GRK7 | 1.29483223 |
| 46 | CDK5 | 1.28091681 |
| 47 | RAF1 | 1.26614383 |
| 48 | NTRK2 | 1.24169305 |
| 49 | MST1R | 1.18003673 |
| 50 | MAP3K6 | 1.13398997 |
| 51 | GRK1 | 0.96712927 |
| 52 | CAMK1G | 0.95738973 |
| 53 | FGFR2 | 0.95421266 |
| 54 | CDK19 | 0.94131213 |
| 55 | CAMK2A | 0.91902546 |
| 56 | CAMKK2 | 0.90313260 |
| 57 | FGFR3 | 0.89896854 |
| 58 | MAP3K1 | 0.88408791 |
| 59 | TNIK | 0.85897431 |
| 60 | RIPK1 | 0.83523633 |
| 61 | PDPK1 | 0.83255521 |
| 62 | PRKCG | 0.80546829 |
| 63 | TAOK1 | 0.78267238 |
| 64 | STK11 | 0.76567975 |
| 65 | RET | 0.75923809 |
| 66 | MATK | 0.75475729 |
| 67 | MAP2K1 | 0.75425079 |
| 68 | CAMK2G | 0.74959477 |
| 69 | LMTK2 | 0.73949412 |
| 70 | PDK1 | 0.72580189 |
| 71 | PRKCI | 0.71850604 |
| 72 | STK38 | 0.70211811 |
| 73 | LATS2 | 0.68558471 |
| 74 | MAP4K2 | 0.60882186 |
| 75 | MST4 | 0.60708417 |
| 76 | PRKCE | 0.59889706 |
| 77 | SGK1 | 0.57762591 |
| 78 | ADRBK2 | 0.57559140 |
| 79 | MAPK11 | 0.57439848 |
| 80 | CAMK1 | 0.57070266 |
| 81 | CAMK2B | 0.56948545 |
| 82 | BMPR1B | 0.55780500 |
| 83 | FYN | 0.55318964 |
| 84 | INSRR | 0.54771716 |
| 85 | ALK | 0.54050614 |
| 86 | MOS | 0.53869267 |
| 87 | NEK1 | 0.53380110 |
| 88 | SYK | 0.53074495 |
| 89 | MAPK13 | 0.52708840 |
| 90 | CSNK1G2 | 0.50692837 |
| 91 | CDK14 | 0.50604669 |
| 92 | TRPM7 | 0.49701841 |
| 93 | BRSK1 | 0.49186450 |
| 94 | CDK18 | 0.49150819 |
| 95 | CDK15 | 0.47747282 |
| 96 | AKT3 | 0.46644160 |
| 97 | MAPKAPK5 | 0.44921159 |
| 98 | FER | 0.43488505 |
| 99 | MAP3K7 | 0.43188875 |
| 100 | PRKCZ | 0.42395957 |
| 101 | PRKACG | 0.42229004 |
| 102 | PRKAA2 | 0.41216698 |
| 103 | MAPK12 | 0.41155404 |
| 104 | WNK1 | 0.40497277 |
| 105 | ERN1 | 0.39596505 |
| 106 | PRPF4B | 0.39551311 |
| 107 | CAMK1D | 0.39453484 |
| 108 | CDK11A | 0.39224263 |
| 109 | PRKACA | 0.39165168 |
| 110 | PIK3CA | 0.38537829 |
| 111 | DYRK1A | 0.38301578 |
| 112 | PAK3 | 0.38284410 |
| 113 | CAMK2D | 0.37618317 |
| 114 | TNK2 | 0.37435840 |
| 115 | PRKCH | 0.36896187 |
| 116 | CSNK1E | 0.36844540 |
| 117 | CSNK1A1 | 0.36716478 |
| 118 | TYRO3 | 0.35926726 |
| 119 | DAPK3 | 0.35874647 |
| 120 | RPS6KA2 | 0.35867534 |
| 121 | CCNB1 | 0.35649467 |
| 122 | SCYL2 | 0.35237791 |
| 123 | PRKAA1 | 0.34657193 |
| 124 | MAP2K2 | 0.34130384 |
| 125 | EPHA3 | 0.33246403 |
| 126 | AKT2 | 0.33102140 |
| 127 | PRKD3 | 0.32953197 |
| 128 | MAP3K5 | 0.32286805 |
| 129 | ERBB3 | 0.32090368 |
| 130 | PRKCQ | 0.31859801 |
| 131 | BMX | 0.31827379 |
| 132 | MAP2K6 | 0.31157593 |
| 133 | ABL2 | 0.30998466 |
| 134 | ERBB2 | 0.30922736 |
| 135 | WNK3 | 0.30237098 |
| 136 | JAK2 | 0.29207583 |
| 137 | DMPK | 0.28688061 |
| 138 | PRKCA | 0.26660924 |
| 139 | PRKCB | 0.26565797 |
| 140 | PRKG2 | 0.26351470 |
| 141 | BLK | 0.26084214 |
| 142 | SGK223 | 0.26004412 |
| 143 | SGK494 | 0.26004412 |
| 144 | RPS6KA3 | 0.25442473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.09103099 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.93943664 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.77103966 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.68092916 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.58607637 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.50101873 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.41489292 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.35767586 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.18872807 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.16372400 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.13636499 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.09641466 |
| 13 | Renin secretion_Homo sapiens_hsa04924 | 2.06141629 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05821831 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 2.03266857 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 2.03038181 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99240628 |
| 18 | Retinol metabolism_Homo sapiens_hsa00830 | 1.95266801 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.92563529 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.84340416 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.83002623 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.82146456 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.81395608 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.75135453 |
| 25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.72946803 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.72825412 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.66924969 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.62781134 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.60877879 |
| 30 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.60415278 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.55975944 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.55130866 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.52931802 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.50565665 |
| 35 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.47123221 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.44826085 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44553226 |
| 38 | Taste transduction_Homo sapiens_hsa04742 | 1.43193878 |
| 39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.42821524 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40549533 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.38752387 |
| 42 | Insulin secretion_Homo sapiens_hsa04911 | 1.38639707 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.37752606 |
| 44 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.36469006 |
| 45 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.34458795 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.33190584 |
| 47 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.30934070 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30675565 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.29772059 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28305603 |
| 51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26167958 |
| 52 | Mineral absorption_Homo sapiens_hsa04978 | 1.25568089 |
| 53 | Cocaine addiction_Homo sapiens_hsa05030 | 1.23769318 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21337605 |
| 55 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.19682693 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.18227095 |
| 57 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.17285152 |
| 58 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.15713891 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15337868 |
| 60 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.15294424 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.14274015 |
| 62 | Gap junction_Homo sapiens_hsa04540 | 1.11040251 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.09610937 |
| 64 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06770814 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.06280379 |
| 66 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03996979 |
| 67 | Bile secretion_Homo sapiens_hsa04976 | 1.03779470 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02098419 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01492575 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.01390034 |
| 71 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.01297222 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.01253586 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00798684 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.99726312 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.99192153 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97642074 |
| 77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.96528173 |
| 78 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.95173166 |
| 79 | Alzheimers disease_Homo sapiens_hsa05010 | 0.93015517 |
| 80 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92387828 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.89356360 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84608976 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84192262 |
| 84 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.84094782 |
| 85 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.81237388 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81191533 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.80760205 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80329577 |
| 89 | Peroxisome_Homo sapiens_hsa04146 | 0.80217156 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77844197 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77521584 |
| 92 | Melanogenesis_Homo sapiens_hsa04916 | 0.73490934 |
| 93 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.72907761 |
| 94 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.72861791 |
| 95 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.71628842 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69282764 |
| 97 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69196051 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68891932 |
| 99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68099633 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67824034 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67450720 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65775955 |
| 103 | Tuberculosis_Homo sapiens_hsa05152 | 0.61771583 |
| 104 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.61577655 |
| 105 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.61107280 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60880600 |
| 107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60605528 |
| 108 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59837904 |
| 109 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59147267 |
| 110 | Axon guidance_Homo sapiens_hsa04360 | 0.58884701 |
| 111 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57967632 |
| 112 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57957567 |
| 113 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.57179708 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57101933 |
| 115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56768272 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56659951 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55870505 |
| 118 | Pertussis_Homo sapiens_hsa05133 | 0.55588396 |
| 119 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53994776 |
| 120 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.53927610 |
| 121 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53861294 |
| 122 | Phagosome_Homo sapiens_hsa04145 | 0.52192890 |
| 123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51152319 |
| 124 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50931154 |
| 125 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50001177 |
| 126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49643117 |
| 127 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49421229 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.47652596 |
| 129 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46911904 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46898817 |
| 131 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46393478 |
| 132 | Platelet activation_Homo sapiens_hsa04611 | 0.45688322 |
| 133 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.44665130 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | 0.42679989 |
| 135 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.42457873 |
| 136 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.41860533 |
| 137 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40339660 |
| 138 | Carbon metabolism_Homo sapiens_hsa01200 | 0.39792341 |
| 139 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39680724 |
| 140 | Parkinsons disease_Homo sapiens_hsa05012 | 0.39003631 |
| 141 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38552535 |
| 142 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.38331625 |
| 143 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.37377436 |
| 144 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.37109184 |
| 145 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35835382 |
| 146 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35278805 |
| 147 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.35046538 |
| 148 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34777615 |
| 149 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33660286 |
| 150 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33280425 |
| 151 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30638824 |

